Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Rivo Health vs StackMD

Rivo Health
Graded #89

Higher grade

vs+8.300000000000004
StackMD
Graded #259

Lower grade

The verdict

Rivo Health takes it — 71.7/100 to 63.4/100.

Rivo Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Rivo Health is a large nationwide GLP-1 telehealth program (115,000+ members, Trustpilot 4.7) offering compounded semaglutide and tirzepatide as both injections and oral options, starting around $149/mo for…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueRivo Health +28
74
46
Dose & formulationRivo Health +21
75
54
Clinical oversightStackMD +1
77
78
Labs & monitoringRivo Health +1
63
62
FulfillmentStackMD +5
84
89
Contract termsStackMD +28
41
69
Rivo Health · left barStackMD · right bar

The numbers

MetricRivo HealthStackMD
WeighScore71.7/10063.4/100
GradeCC
Scorecard rank#89#259
Semaglutide$149/mo (compounded)$125/mo (1 mg dose, plus a separate fee, compounded)
Tirzepatide$199/mo (compounded)$199/mo (5 mg dose, compounded)
CoverageAll 50 statesAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesInjection only
Rivo Health

Graded #89 · C

Strengths

  • Compounded semaglutide and tirzepatide as both injections and oral options, starting around $149/mo (sema) and $199/mo (tirz)
  • Bundles dietitians, live workouts, support groups and mental-health coaching with the medication, not just a prescription
  • Insurance concierge to maximize coverage, FSA/HSA eligible, with multi-month plans that cut the price further
  • Large, established program (115,000+ members, Trustpilot 4.7) available nationwide

Where it loses points

  • Uses partner compounding pharmacies it doesn't name on the site
  • Headline prices are Spring-sale rates — everyday cost is higher and the deepest discounts need a 6-month commitment
  • Weight loss is one of several verticals (ED, longevity, sleep, hair, skin), not a single focus
  • Some bundled perks (e.g. meal prep) are paid add-ons rather than included
StackMD

Graded #259 · C

Strengths

  • Publishes an exact price for every dose strength rather than a single 'from' figure — semaglutide $125-$225, tirzepatide $199-$449
  • Names both its legal entity (Medical 360 HC PLLC) and its prescribing telehealth partner, SamaritanMD
  • No membership or platform fee — the medication price is the whole price
  • States plainly that its compounded medications are 'not FDA-approved and have not been evaluated by the FDA for safety, efficacy, or quality'
  • Telehealth offered in all 50 states per its terms, with free discreet shipping and FSA/HSA eligibility

Where it loses points

  • All sales are final — 'No refunds are issued except as described below', and dispensed medication cannot be returned
  • Compounding pharmacies are never named, only 'a licensed third-party pharmacy'
  • Price rises steeply with dose: tirzepatide runs $199 at 5mg to $449 at 30mg
  • Billing and refunds are handled by SamaritanMD — StackMD 'has no authority to issue refunds' on its behalf
  • Terms impose binding arbitration in New York and waive jury trial and class-action participation

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard